How Interoperability, Data Infrastructure Create New Opportunities for Pharmacies | NCPDP 2025
Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.
Pharmacists’ Role in Remote Patient Care Dependent on Data Infrastructure | NCPDP 2025
In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists’ role in remote patient care amid a growing technological infrastructure.
How Digital Prescription Solutions Can Overcome Pharmacy Challenges | NCPDP 2025
In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.
The Use of Geographical Information Systems to Improve Vaccine Services, Uptake | NCPDP 2025
In her expertise as a leader with the American Pharmacists Association, Brigid Groves, PharmD, MS, provides insights into her work with geographical information systems and maps.
Pharmacy Centralization Creates More Opportunities for Pharmacists | NCPDP 2025
Vin Gupta, MD, discusses trends and perspectives in patient data privacy as well as what a “smart pharmacy” may look like in the near future.
What Recent PBM Updates Mean for Pharmacy in 2025 | NCPDP 2025
Cami Agena, Esq, and Candida Ruesga, Esq, discuss pharmacy benefit manager reform by providing insights from their experience as legal partners in complex PBM matters.
How Pharmacists Are Becoming More Connected as Providers Through Interoperability | NCPDP 2025
Larry King, PharmD, discusses how pharmacy interoperability is working to create collaborative care and get pharmacists “in the game” as he says.
President Trump Signs Executive Order Significantly Decreasing US Drug Prices
The order is set to make patients’ prescription costs similar to other nations with the lowest-priced drugs in the world.
Q&A: Douglas Hoey on How Rite Aid’s Closure Will Impact Independent Pharmacies
Douglas Hoey, CEO of NCPA, discusses what independent pharmacies can do to handle an influx of patients and what the chain’s situation means for the pharmacy landscape.
Pharmacists Best-Positioned to Address Social Determinants of Health | NCPDP 2025
Vin Gupta, MD, former Chief Medical Officer at Amazon Pharmacy and renowned US medical analyst, discusses pharmacists’ ability to reach communities and address social determinants of health.
Digital Prescription Solutions for Better Patient Transparency | NCPDP 2025
Miranda Rochol, Senior Vice President of Provider Solutions at Prescryptive Health, discusses digital prescription solutions and how they are turning patients into consumers.
How Community Pharmacies Have Become Key Vaccination Destinations | NCPDP 2025
Brigid Groves, PharmD, MS, Vice President of Professional Affairs at APhA, discusses how the pharmacist’s role in immunization has adapted in recent history.
Demystifying PBMs, Their Role in the Drug Supply Chain
President of 3 Axis Advisors and CEO of 46brooklyn Research joins Drug Topics to discuss nuances surrounding pharmacy benefit managers and the way they are perceived in the public eye.
Rite Aid’s Closure is a Call to Action to Address Pharmacy Payment Model
A conversation with Douglas Hoey, RPh, MBA, CEO of NCPA, on the chain pharmacy’s announcement of a second Chapter 11 bankruptcy.
Dispensing Leadership: Finding Solutions
In this episode of the podcast, Shawn and Jesse discuss how every situation has a solution and the best way to find it.
Misconceptions Surrounding the Frictional PBM-Pharmacist Relationship
Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses the commonly circulated misconceptions about PBMs.
Q&A: As Closures Mount, Independent Pharmacies Must Diversify Services
Douglas Hoey, CEO of NCPA, discusses what pharmacies can do to increase revenue and avoid shutting their doors.
Q&A: Borrowing the Disney Touch for Better Pharmacy Customer Service | AAP 2025
A conversation with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, clinical assistant professor and director of experiential learning at West Virginia University School of Pharmacy, at AAP 2025.
How PBMs Gained Notoriety in the Prescription Drug Market
Expert on drug pricing and pharmacy benefits, Antonio Ciaccia joined Drug Topics to discuss how PBMs came to hold so much control of the pharmaceutical supply chain.
Q&A: Strategic Vaccine Management Can Drive Pharmacy Success | AAP 2025
A conversation with Greg Mitchell, owner of United Drug Superstore in Hatch, New Mexico, at AAP 2025.
Pharmacists’ Role Amid Increased Drug Advertising on Social Media
Luke Turnock, PhD, discusses the role of pharmacists and medication counselors in addressing the challenges of increased direct-to-consumer drug advertising on social media.
Significant Barriers Exist in General Practice Independent Pharmacist Prescribing
Researchers explored the confidence, barriers, and role of general practice independent pharmacists regarding prescribing services within primary care settings.
The 3 Types of PBM Reform Aiming to Change the Pharmaceutical Market
Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses litigious, market-based, and legislative reform for pharmacy benefit managers.
Naloxone Training Varies at Independent, Chain Pharmacies
Researchers identified differences in naloxone training, policies, procedures, and preferences among chain or independent pharmacies across Alabama.